New Results
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S. Piepenbrink, Jun-Gyu Park, Fatai S. Oladunni, Ashlesha Deshpande, Madhubanti Basu, Sanghita Sarkar, Andreas Loos, Jennifer Woo, Phillip Lovalenti, Derek Sloan, Chengjin Ye, Kevin Chiem, Nathaniel B. Erdmann, Paul A. Goepfert, Vu L. Truong, Mark R. Walter, Luis Martinez-Sobrido, James J. Kobie
doi: https://doi.org/10.1101/2020.10.14.339150
Michael S. Piepenbrink
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Jun-Gyu Park
bTexas Biomedical Research Institute, San Antonio, TX, USA
Fatai S. Oladunni
bTexas Biomedical Research Institute, San Antonio, TX, USA
Ashlesha Deshpande
cDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA
Madhubanti Basu
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Sanghita Sarkar
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Andreas Loos
dAridis Pharmaceuticals Inc., San Jose CA, USA
Jennifer Woo
dAridis Pharmaceuticals Inc., San Jose CA, USA
Phillip Lovalenti
dAridis Pharmaceuticals Inc., San Jose CA, USA
Derek Sloan
dAridis Pharmaceuticals Inc., San Jose CA, USA
Chengjin Ye
bTexas Biomedical Research Institute, San Antonio, TX, USA
Kevin Chiem
bTexas Biomedical Research Institute, San Antonio, TX, USA
Nathaniel B. Erdmann
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Paul A. Goepfert
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
cDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA
Vu L. Truong
dAridis Pharmaceuticals Inc., San Jose CA, USA
Mark R. Walter
cDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA
Luis Martinez-Sobrido
bTexas Biomedical Research Institute, San Antonio, TX, USA
James J. Kobie
aDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Article usage
Posted October 14, 2020.
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S. Piepenbrink, Jun-Gyu Park, Fatai S. Oladunni, Ashlesha Deshpande, Madhubanti Basu, Sanghita Sarkar, Andreas Loos, Jennifer Woo, Phillip Lovalenti, Derek Sloan, Chengjin Ye, Kevin Chiem, Nathaniel B. Erdmann, Paul A. Goepfert, Vu L. Truong, Mark R. Walter, Luis Martinez-Sobrido, James J. Kobie
bioRxiv 2020.10.14.339150; doi: https://doi.org/10.1101/2020.10.14.339150
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S. Piepenbrink, Jun-Gyu Park, Fatai S. Oladunni, Ashlesha Deshpande, Madhubanti Basu, Sanghita Sarkar, Andreas Loos, Jennifer Woo, Phillip Lovalenti, Derek Sloan, Chengjin Ye, Kevin Chiem, Nathaniel B. Erdmann, Paul A. Goepfert, Vu L. Truong, Mark R. Walter, Luis Martinez-Sobrido, James J. Kobie
bioRxiv 2020.10.14.339150; doi: https://doi.org/10.1101/2020.10.14.339150
Subject Area
Subject Areas
- Biochemistry (11740)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17410)
- Clinical Trials (138)
- Developmental Biology (9420)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12239)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28070)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)